Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2005
08/24/2005EP1566378A1 Isoindoline derivative
08/24/2005EP1565459A2 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors
08/24/2005EP1565458A2 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents
08/24/2005EP1565457A2 Process for synthesis bis-aryl diamidoxime compounds
08/24/2005EP1565456A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
08/24/2005EP1565455A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
08/24/2005EP1565452A2 3-substituted-6-aryl pyridines as ligands of c5a receptors
08/24/2005EP1565446A1 Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
08/24/2005EP1565442A1 Pyridine derivatives as cb2 receptor modulators
08/24/2005EP1565436A2 3-aminopyrrolidine derivatives as modulators of chemokine receptors
08/24/2005EP1565428A1 Substituted ureas and carbamates
08/24/2005EP1565192A2 Method and compositions for temporarily incapaciting subjets
08/24/2005EP1565187A2 Methods of treating cancer and related methods
08/24/2005EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
08/24/2005EP1370558B1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
08/24/2005EP1292190B1 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives
08/24/2005EP1244652B1 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
08/24/2005EP1214304B1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
08/24/2005EP1158980B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
08/24/2005EP1124804B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
08/24/2005CN1659931A 场致发光器件 Electroluminescent devices
08/24/2005CN1659640A Optical data carrier comprising a cationic aminoheterocyclic dye as light-absorbent compound in the information layer
08/24/2005CN1659165A Quinolinone derivatives
08/24/2005CN1659162A Tricyclic thrombin receptor antagonists
08/24/2005CN1659161A Piperidine derivatives having CCR3 antagonism
08/24/2005CN1659155A 1-phenylalkyl-piperazines
08/24/2005CN1659153A PNA monomer and precursor
08/24/2005CN1659151A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/24/2005CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
08/24/2005CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
08/24/2005CN1658875A 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists
08/24/2005CN1658874A (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists
08/24/2005CN1658871A Amide derivatives as GK activators
08/24/2005CN1658866A Tri-substituted heteroaryls and methods of making and using the same
08/24/2005CN1658724A Luminescent element material and luminescent element comprising the same
08/24/2005CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor
08/24/2005CN1216055C Paroxetine hydrochloride anhydrous compound and its preparation method and use
08/24/2005CN1216053C 2,2-disubstituted 1,3-dioxolanes as antitussive atents
08/24/2005CN1216050C 5,6,7-trinor -4,8-inter-m-phenylene PGI2 derivative and drugs containing the same
08/24/2005CN1216018C Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
08/24/2005CN1215835C Ketone derivatives and medical use thereof
08/23/2005US6933393 Reacting methyl cyanoacetate with morphiline to form 3-morpholin-4-yl-3-oxo- propionitrile; forming salt; reacting with phenylacetic acid and 2-(2-(4-fluorophenyl)-2-oxo-1-phenyl-ethyl)-4-
08/23/2005US6933384 Synthetic molecules for labeling histidine-rich proteins
08/23/2005US6933316 Indole compounds
08/23/2005US6933314 Integrin receptor inhibitors
08/23/2005US6933311 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
08/23/2005US6933305 Amide compounds and use thereof
08/23/2005US6933304 Antitumor agents, osteoporosis
08/23/2005US6933299 Anilinoquinazolines as protein tyrosine kinase inhibitors
08/23/2005US6933298 Matrix metalloproteinase inhibitor; osteoporosis, antiarthritic agents, rheumatic diseases
08/23/2005US6933296 A 2H-pyridazine-1-one derivatives as bronchodilator agents for the treatment of asthma, chronic obstructive pulmonary disease, respiratory system disorders
08/23/2005US6933288 Pyranosyl cytosines: pharmaceutical formulations and methods
08/23/2005US6933261 2,4,5-Trisubstituted phenylketoenols
08/23/2005CA2469592C Hiv integrase inhibitors
08/23/2005CA2064373C Piperidine derivatives
08/18/2005WO2005075464A1 Pyridine derivatives as connabinoid receptor modulators
08/18/2005WO2005075463A1 Benzopyran derivatives, method of production and use thereof
08/18/2005WO2005075462A1 Coupling reactions useful in the preparation of (1h-tetrazol-5-yl)-biphenyl derivatives
08/18/2005WO2005075458A1 Pyrimidine derivatives as orexin receptors antagonists
08/18/2005WO2005075456A1 2-(piperidin-4-yl) -4, 5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors
08/18/2005WO2005075451A1 Aminodibenzodioxin derivative and organic electroluminescent device using same
08/18/2005WO2005075440A1 2- (phenylamino) -pyrimidin-5-amides as cannabinoid 2 receptors modulators for the treatment of immune or inflammatory disorders
08/18/2005WO2005075436A2 Novel inhibitors of glutaminyl cyclase
08/18/2005WO2005075435A1 Modulators of atp-binding cassette transporters
08/18/2005WO2005075429A1 Novel quinoline-carbaxamides as jack3 kinase modulators
08/18/2005WO2005075426A1 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
08/18/2005WO2005075421A1 Bicycloester derivative
08/18/2005WO2005074654A2 Methods to manufacture 1,3-dioxolane nucleosides
08/18/2005WO2005040345A3 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase
08/18/2005WO2005030794A3 Hemiasterlin derivatives and uses thereof
08/18/2005US20050182130 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
08/18/2005US20050182116 Such as 5-amino-3-[[4-(aminosulfonyl)phenyl]amino]-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide, used as cyclin dependent and tyrosine kinase inhibitors, for prophylaxis of tumors
08/18/2005US20050182115 Agent for preventing and/or treating sinusitis
08/18/2005US20050182098 Administering taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions for inhibiting tumor growth
08/18/2005US20050182094 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens
08/18/2005US20050182093 Novel compounds
08/18/2005US20050182061 Phthalimide compounds useful as protein kinase inhibitors
08/18/2005US20050182054 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
08/18/2005US20050182050 Therapeutic heterocyclic compounds
08/18/2005US20050182048 Paraciticides for use on or in animals, against insects, arachnids and nematodes; 1-(haloalkyl-substituted aryl)-3-cyano-4-alkylthio-5-(alkylthioalkylamino)pyrazoles or S-oxides thereof
08/18/2005US20050182043 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders
08/18/2005US20050182041 N-Benzoylazetidines, e.g., N-(3,5-di-tert-butyl-4-hydroxybenzoyl)-3-hydroxyazetidine; cyclooxygenase-1 and/or cyclooxygenase-2 inhibitors; treating inflammatory diseases including various kinds of arthritis, lupus, dysmenorrhea, ankylosing spondylitis, edema, migraines, and aplastic anemia
08/18/2005DE102004004787A1 New effector-linker and effector-recognition unit conjugates derived from epothilones, useful as targeted drugs for treating proliferative diseases, e.g. tumors or neurodegenerative disease
08/18/2005DE102004002884A1 New aspernigrin B derivatives are intracellular calcium ion concentration reducing neuroprotective agents, useful for treating neurodegenerative diseases e.g. Parkinson's disease and multiple sclerosis
08/18/2005CA2554809A1 Novel n-alkyl thiourea-and thioamide-substituted imidazolyl inhibitors and glutaminyl cyclase
08/18/2005CA2554796A1 Modulators of atp-binding cassette transporters
08/18/2005CA2554782A1 Methods to manufacture 1,3-dioxolane nucleosides
08/18/2005CA2553246A1 Coupling reactions useful in the preparation of (1h-tetrazol-5-yl)-biphenyl derivatives
08/17/2005EP1564215A1 Process for preparing glycidylphthalimide
08/17/2005EP1562941A2 Trans-9,10-dehydroepothilone c and d, analogs thereof and methos of making the same
08/17/2005EP1562937A2 N-substituted piperidine derivatives as serotonin receptor agents
08/17/2005EP1562934A1 Amino-heterocycles as vr-1 antagonists for treating pain
08/17/2005EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders
08/17/2005EP1562928A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
08/17/2005EP1562911A1 Compositions useful as inhibitors of jak and other protein kinases
08/17/2005EP1562903A2 Mucin synthesis inhibitors
08/17/2005EP1562898A1 Indole derivatives as somatostatin agonists or antagonists
08/17/2005EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/17/2005EP1562595A1 Diaryl ethers as opioid receptor antagonists
08/17/2005EP1562589A2 Diaminotriazoles useful as inhibitors of protein kinases
1 ... 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 ... 694